benzbromarone has been researched along with Obesity in 4 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, P | 1 |
| Zhu, JJ | 1 |
| Wang, T | 1 |
| Huang, Q | 1 |
| Zhou, YR | 1 |
| Yu, BW | 1 |
| Jiang, HL | 1 |
| Wang, HY | 1 |
| Asch, L | 1 |
| Schirardin, H | 1 |
| Weryha, A | 1 |
| Schräpler, P | 1 |
| Kleinschmidt, A | 1 |
| Haese, E | 1 |
| Siegenthaler-Zuber, G | 1 |
1 trial available for benzbromarone and Obesity
| Article | Year |
|---|---|
[The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
Topics: Adolescent; Adult; Benzbromarone; Benzofurans; Fasting; Female; Humans; Male; Middle Aged; Obesity; | 1978 |
3 other studies available for benzbromarone and Obesity
| Article | Year |
|---|---|
Benzbromarone aggravates hepatic steatosis in obese individuals.
Topics: Adult; Aged; Animals; Apoptosis; Benzbromarone; Chemical and Drug Induced Liver Injury; Diet, High-F | 2018 |
[Erythrocyte uric acid in the non-gouty subject].
Topics: Benzbromarone; Erythrocytes; Humans; Obesity; Renal Dialysis; Uric Acid | 1980 |
[Which uric acid value is in need of treatment?].
Topics: Allopurinol; Benzbromarone; Citrates; Coronary Disease; Gout; Humans; Hyperlipidemias; Hypertension; | 1976 |